Inhaled triple therapy in chronic obstructive pulmonary disease

Affiliations

¹ Department of Pharmacology, University of Bordeaux, Bordeaux 33076, France. Electronic address: mathieu.molimard@u-bordeaux.fr.
² Department of Pharmacology, University of Bordeaux, Bordeaux 33076, France.

Comment

Mathieu Molimard et al. Lancet. 2018.

. 2018 Sep 29;392(10153):1112.

doi: 10.1016/S0140-6736(18)31798-7.

¹ Department of Pharmacology, University of Bordeaux, Bordeaux 33076, France. Electronic address: mathieu.molimard@u-bordeaux.fr.
² Department of Pharmacology, University of Bordeaux, Bordeaux 33076, France.

No abstract available

Comment on

Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial.
Papi A, Vestbo J, Fabbri L, Corradi M, Prunier H, Cohuet G, Guasconi A, Montagna I, Vezzoli S, Petruzzelli S, Scuri M, Roche N, Singh D. Papi A, et al. Lancet. 2018 Mar 17;391(10125):1076-1084. doi: 10.1016/S0140-6736(18)30206-X. Epub 2018 Feb 9. Lancet. 2018. PMID: 29429593 Clinical Trial.